Why CGM transforms diabetes management
CGMs estimate interstitial glucose at model-specific intervals. Original Libre 3 reports every minute and G7 every five minutes; Stelo sensor transmission and app display intervals differ. Features and intended uses must be checked for the exact model.
Trend arrows show not just where your glucose is but where it's going and how fast. A reading of 120 mg/dL with a rapidly falling arrow requires a different response than 120 mg/dL with a stable arrow. This context is impossible to get from a finger stick.
Overnight monitoring with a suitable low-glucose alarm can help detect and reduce lows during sleep, when symptoms may not wake you (ADA Standards of Care 2026, Section 7). Blood glucose meters, treatment adjustments, education and clinical plans also play a role in preventing and treating lows. Nocturnal hypoglycemia is one of the serious risks in intensive diabetes management.
Meal and activity logs can be compared with glucose observations, but a trace cannot prove a sleep, stress or food cause. Laboratory HbA1c reflects roughly three months with greater weight on recent glucose; it can change before three months and complements CGM.
CGM for Type 1 diabetes
Compatible automated insulin delivery systems use CGM information to support insulin delivery. Suitability and settings depend on the exact cleared system and individualized care plan.
Closed-loop AID systems — where a CGM communicates directly with an insulin pump to automatically adjust insulin delivery — require a compatible CGM. The Dexcom G7 works with several AID systems, including Tandem t:slim X2 (Control-IQ), Omnipod 5 and others; check your pump's current CGM list.
For diabetes management, choose the exact CGM with your care team. Confirm intended use, alerts and current pump/software compatibility; no one device is best for all people with type 1 diabetes.
Coverage depends on the exact device, plan, documentation and supplier. Medicare requires all applicable criteria, including diabetes, a prescription, training, FDA-consistent use, required visits and insulin treatment or documented problematic hypoglycemia. Ask your insurer and prescriber about your situation.
CGM for Type 2 diabetes
The role of CGM in type 2 diabetes depends on treatment and clinical needs. MOBILE studied adults using basal but not mealtime insulin; its results do not establish the same benefit for every non-insulin user.
In DIAMOND, adults with type 1 diabetes using multiple daily insulin injections had an adjusted between-group HbA1c difference of 0.6 percentage points at 24 weeks with CGM versus usual monitoring. In MOBILE, adults with poorly controlled type 2 diabetes using basal but not mealtime insulin had a 0.4-point between-group difference at eight months. These results apply to those treatment programs and populations. Coverage depends on the exact device, plan, documentation and supplier. Medicare requires all applicable criteria, including diabetes, a prescription, training, FDA-consistent use, required visits and insulin treatment or documented problematic hypoglycemia. Ask your insurer and prescriber about your situation.
For non-insulin treatment, discuss the potential role of CGM with your clinician. Neither non-insulin use nor a diabetes diagnosis alone establishes OTC suitability or insurance coverage; problematic hypoglycemia and medications such as sulfonylureas require clinical context.
Best CGM devices for diabetes 2026
Dexcom G7: confirm the exact pump, software, alert and watch compatibility. Read the review →
FreeStyle Libre 3 — 7.8% MARD in Abbott's own pivotal trial (not directly comparable with other devices' figures), 14-day wear. An option for people not using closed-loop AID. Full review →
Guardian 4: a sensor for compatible Medtronic systems. Integration does not establish compensation for sensor inaccuracy.
All three devices above require a prescription. OTC CGMs (Stelo, Lingo) are not appropriate for insulin-using diabetes management — they lack the clinical alerts and insulin-dosing clearance needed for safe diabetes care.
How to get started with CGM
Step 1: Talk to your endocrinologist or diabetes care provider. Ask specifically about CGM and which device is best for your management approach (AID system compatibility, insulin regimen, etc.).
Step 2: Get a prescription. Your prescriber will write a CGM prescription and may also handle prior authorization with your insurer.
Step 3: Verify insurance coverage. Contact your insurer and confirm which devices are covered on your plan's formulary and what your cost-sharing will be.
Obtain the prescribed system through a suitable supplier. Setup and warm-up depend on the model; follow its instructions and training rather than a universal time estimate.
Frequently asked questions
Sources & Further Reading
This article draws on the following clinical sources:
- American Diabetes Association. Standards of Medical Care in Diabetes 2026. diabetesjournals.org/care →
- CDC. National Diabetes Statistics Report. cdc.gov/diabetes →
- Continuous Glucose Monitoring Consensus Conference Report. Diabetes Care. PubMed →
- Dexcom G7: FDA decision summary K213919. FDA decision summary →